Antioxidants in critical illness

Archives of Surgery

Volumn 136, Issue 10, 2001, Pages 1201-1207

  Bulger, Eileen M ^a   Maier, Ronald V ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALLOPURINOL; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CATALASE; LAZAROID; METHYLPREDNISOLONE; SELENIUM; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; CRITICAL ILLNESS; CYTOTOXICITY; DRUG ACTIVITY; DRUG MECHANISM; HUMAN; ISCHEMIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION; REVIEW; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0034816998     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.136.10.1201     Document Type: Review

References (95)

1. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1
2. Inhibition of Nf-kB activation by vitamin E derivatives
3. Function and activation of NF-kB in the immune system
4. Antioxidant and redox regulation of gene transcription
5. Role of oxidants and antioxidants in the induction of AP-1, NF-kB, and glutathione S-transferase gene expression
6. Regulation of the transcription factors NF-kB and AP-1 by redox changes
7. Interactions among antioxidants in health and disease; vitamin E and its redox cycle
8. Mechanisms of stabilization of biomembranes by alpha-tocopherol
9. α-Tocopherol and protein kinase C regulation of intracellular signaling
10. The differential effects of the membrane antioxidant: Vitamin E on macrophage activation
11. The role of vitamin E as a modulator of macrophage activation
12. Antioxidants attenuate endotoxin induced activation of alveolar macrophages
13. Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts: A role for lipid peroxidation?
14. The physiological role of zinc as an antioxidant
15. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction
16. Plasma lipid peroxides and alpha-tocopherol in critically ill patients
17. Antioxidant status in patients with acute respiratory distress syndrome
18. Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis
19. Plasma levels of glutathione, alpha-tocopherol and lipid peroxides in polytraumatized patients: Evidence for a stimulating effect of TNF alpha on glutathione synthesis
20. Differences in tocopherol-lipid ratios in ARDS and non-ARDS patients
21. Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome
22. Vitamin E deficiency and lipoperoxidation during adult respiratory distress syndrome
23. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients
24. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk
25. Alteration of erythrocyte glutathione, cysteine and glutathione synthetase in alcoholic and non-alcoholic cirrhosis
26. N-acetylcysteine enhances recovery from acute lung injury in man: A randomized, double-blind, placebo-controlled clinical study
27. Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome
28. Plasma antioxidant potential in severe sepsis: A comparison of survivors and nonsurvivors
29. Decreased total antioxidant capacity but normal lipid hydroperoxide concentrations in sera of critically ill patients
30. Measures of total free radical activity in critically ill patients
31. Total plasma antioxidant capacity is not always decreased in sepsis
32. Is the endogenous peroxyl-radical scavenging capacity of plasma protective in systemic inflammatory disorders in humans?
33. The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid
34. N-acetylcysteine administration in the critically ill
35. GSH rescue by N-acetylcysteine
36. Protective effects of N-acetylcysteine on hypothermic ischemia-reperfusion injury of rat liver
37. N-acetyl cysteine attenuates acute lung injury in the rat
38. Effects of n-acetylcysteine in a rat model of ischemia and reperfusion injury
39. N-acetyl-L-cysteine for preventing lung reperfusion injury after liver ischemia-reperfusion: A possible dual protective mechanism in a dose-response study
40. Characterization and reduction of ischemia/reperfusion injury after experimental pancreas transplantation
41. N-acetyl cysteine ameliorates ischemic renal failure
42. Postinsult treatment with N-acetyl-L-cysteine decreases IL-1-induced neutrophil influx and lung leak in rats
43. Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function
44. Protection against pulmonary O2 toxicity by N-acetylcysteine
45. Effect of N-acetylcysteine on pulmonary damage due to microembolism in the rat
46. Liposomal antioxidants provide prolonged protection against acute respiratory distress syndrome
47. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome, a prospective, randomized, placebo-controlled study
48. A trial of antioxidants N-acetylcysteine and procysteine in ARDS: The Antioxidant in ARDS Study Group
49. Treatment with N-acetylcysteine during acute respiratory distress syndrome: A randomized, double-blind, placebo-controlled clinical study
50. Protective effects of N-acetylcysteine and rutin on the lipid peroxidation of the lung epithelium during the adult respiratory distress syndrome
51. Oxidant-antioxidant balance in granulocytes during ARDS: Effect of N-acetylcysteine
52. The effect of N-acetylcysteine on total serum anti-oxidant potential and urinary albumin excretion in critically ill patients
53. Does N-acetylcysteine improve hemodynamics and graft function in liver transplantation?
54. The efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantation
55. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: Results from a prospective, randomized, double-blind study
56. The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock
57. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine
58. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: A prospective controlled trial
59. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome
60. Changes in the levels of endogenous antioxidants in the liver of mice with experimental endotoxemia and the protective effects of antioxidants
61. Lipid peroxidation in experimental septic rats
62. Effect of oxygen-free radical scavengers on survival in sepsis
63. Modification by oxygen free radical scavengers of the metabolic and cardiovascular effects of endotoxin infusion in conscious rats
64. The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants
65. Endotoxin-induced disseminated intravascular coagulation in vitamin E deficient rats
66. The effect of pretreatment with vitamin E on the effects of endotoxin on rat
67. Alpha-tocopherol attenuates lung edema and lipid peroxidation caused by acute zymosan-induced peritonitis
68. Role of free radicals in ischemic rat liver cell injury: Prevention of damage by alpha-tocopherol administration
69. Protective effects of alpha-tocopherol and coenzyme Q10 on warm ischemic damages of the rat kidney
70. Enteral vitamin E supplementation inhibits the cytokine response to endotoxin
71. The effects of alpha-tocopherol supplementation on monocyte function
72. Serum alpha-tocopherol levels after high-dose enteral vitamin E administration in patients with acute respiratory failure
73. Ascorbyl radical formation in patients with sepsis: Effect of ascorbate loading
74. Effect of allopurinol and superoxide dismutase on survival rate in rats with sepsis
75. Effect of scavengers of oxygen-derived free radicals on mortality in endotoxin-challenged mice
76. High dose superoxide dismutase potentiates respiratory failure in septicemia
77. Potentiation of lung vascular response to endotoxin by superoxide dismutase
78. Evidence for lack of importance of oxygen-free radicals in Escherichia coli endotoxemia in dogs
79. Vitamin E supplementation in the critically ill patient: Too narrow a view?
80. The effects of intravenous antioxidants in patients with septic shock
81. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome: Enteral Nutrition in ARDS Study Group
82. Free radical scavenging by lazaroids improves renal blood flow during sepsis
83. Lazaroid improves intestinal blood flow in the rat during hyperdynamic bacteraemia
84. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a "second generation" lazaroid in rats
85. Functional alterations of alveolar macrophages subjected to smoke exposure and antioxidant lazaroids
86. Effects of the lazaroid, tirilazad mesylate, on sepsis-induced acute lung injury in minipigs
87. The protective action of allopurinol in an experimental model of haemorrhagic shock and reperfusion
88. Allopurinol plus standard resuscitation preserves hepatic blood flow and function following hemorrhagic shock
89. Hemorrhagic shock-induced bacterial translocation is reduced by xanthine oxidase inhibition or inactivation
90. Interaction of platelet activating factor, reactive oxygen species generated by xanthine oxidase, and leukocytes in the generation of hepatic injury after shock/resuscitation
91. Inhibition of lipid peroxidation improves survival rate of endotoxemic rats
92. Experiences with allopurinal in canine endotoxin shock
93. Free radical generation and the role of allopurinol as a cardioprotective agent during coronary artery bypass grafting surgery
94. Improvement of cardiac function by allopurinol in patients undergoing cardiac surgery
95. Allopurinol pretreatment improves post-operative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting